Related Experiment Videos
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation
Miranda Thomas1, Richard Laura, Karin Hepner
1International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34012 Trieste, Italy.
Abstract:
The E6 proteins from the high-risk human papillomavirus (HPV) types have previously been shown to target a number of PDZ domain-containing proteins for proteasome-mediated degradation. These include the hDlg tumour suppressor and the MAGI-1 protein. In this study we show that high-risk HPV E6 proteins also target the related MAGI-2 and MAGI-3 proteins for degradation. Moreover, we show that the interaction is specific to one PDZ domain, and that co-expression of this domain can protect each of the full-length MAGI proteins from E6-mediated degradation. These data provide clear indicators for the potential design of compounds that could specifically inhibit the interaction of oncogenic HPV E6 proteins with an important class of target proteins.
Insights
High-risk human papillomavirus (HPV) E6 proteins degrade MAGI-2 and MAGI-3 proteins. Targeting a specific PDZ domain could inhibit this interaction, offering a potential therapeutic strategy against HPV.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- High-risk human papillomavirus (HPV) E6 oncoproteins are known to target PDZ domain-containing proteins, such as hDlg and MAGI-1, for proteasomal degradation.
- This degradation mechanism is implicated in viral oncogenesis and tumor progression.
Purpose of the Study:
- To investigate whether high-risk HPV E6 proteins also target MAGI-2 and MAGI-3 proteins for degradation.
- To determine the specificity of the interaction between HPV E6 and MAGI proteins within the PDZ domain.
- To explore the potential for therapeutic intervention by inhibiting E6-MAGI protein interactions.
Main Methods:
- Co-immunoprecipitation assays to detect protein-protein interactions.
- Western blotting to assess protein levels and degradation.
- Expression of full-length MAGI proteins and isolated PDZ domains in cell culture systems.
Main Results:
- High-risk HPV E6 proteins were shown to induce the degradation of MAGI-2 and MAGI-3 proteins.
- The interaction between HPV E6 and MAGI proteins was found to be specific to a single PDZ domain.
- Co-expression of this specific PDZ domain conferred protection to full-length MAGI proteins against E6-mediated degradation.
Conclusions:
- Oncogenic HPV E6 proteins target MAGI-2 and MAGI-3 for proteasomal degradation, expanding the known repertoire of E6 targets.
- The interaction is mediated by a specific PDZ domain, highlighting a potential Achilles' heel for therapeutic targeting.
- These findings provide a strong rationale for designing compounds that inhibit the E6-PDZ domain interaction to counteract the effects of oncogenic HPV.